Need an investment idea? Check out S2O Stock Screener. It allows to generate a list of stocks of a particular interest in a matter of seconds!

Market Price

192.40 

5.38 2.9%

as of May 14 '21

52 Week Range:

75.63 217.17


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

Heska Corporation manufactures, sells, and markets veterinary diagnostic and specialty products for canine and feline healthcare markets in the United States, Canada, Europe, and internationally. The company's Core Companion Animal Health segment offers Element DC and DRI-CHEM 7000 veterinary chemistry analyzers for blood chemistry and electrolyte analysis; HT5 and HEMATRUE veterinary hematology analyzers to measure blood cell and platelet count, and hemoglobin levels; Element POC blood gas and electrolyte analyzers; COAG veterinary analyzers; Element i immunodiagnostic analyzers; and IV infusion pumps. This segment also provides veterinary imaging instruments and services, such as digital radiography solutions and ultrasound systems, as well as sells mobile digital radiography products; Cloudbank, a Web-based image storage solution; ViewCloud, a picture archival and communications system for Cloudbank; point-of-care heartworm diagnostic test products for dogs and cats; TRI-HEART Plus chewable tablets for the treatment of canine heartworm infection, and treatment and control of ascarid and hookworm infections; and allergy products and services, including ALLERCEPT definitive allergen panels, and therapy shots or drops. Its Other Vaccines, Pharmaceuticals and Products segment offers bovine vaccines primarily under the Titanium and MasterGuard brands; biological and pharmaceutical products for other animal health companies; and turnkey services comprising research, licensing, production, labeling, and packaging. The company sells its products to veterinarians through a field organization and third-party distributors; and trade shows, print advertising, and other distribution relationships. Heska Corporation has product development partnership and licensing agreement with MBio Diagnostics, Inc. The company was formerly known as Paravax, Inc. and changed its name to Heska Corporation. Heska Corporation was founded in 1988 and is headquartered in Loveland, Colorado.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19 Dec '20
Equity (BVPS) 8.75
9.13
9.10
8.36
8.09
8.93
11.36
13.83
14.54
19.50
29.01
growth rate 4.3% -0.3% -8.1% -3.2% 10.4% 27.2% 21.7% 5.1% 34.1% 48.8%
Earnings BIT 0.07
3.37
2.02
-1.39
2.91
8.56
16.53
18.22
3.79
0.33
1.31
growth rate 4,784.1% -40.1% -100.0% 100.0% 194.0% 93.2% 10.2% -79.2% -91.4% 300.0%
Avg.PE 1,428.57
18.18
36.90
31.87
62.10
47.52
67.87
59.10
106.67
106.67
106.67
growth rate -98.7% 103.0% -13.6% 94.9% -23.5% 42.8% -12.9% 80.5% 0.0% 0.0%
ROA 0.03
3.43
1.87
-1.49
2.73
5.07
8.74
7.47
4.00
-0.73
-4.47
growth rate 11,333.3% -45.5% -100.0% 100.0% 85.7% 72.4% -14.5% -46.5% -100.0% 0.0%
ROE 0.04
4.55
2.47
-2.41
5.02
8.98
13.96
10.62
5.25
-1.06
-6.52
growth rate 11,275.0% -45.7% -100.0% 100.0% 78.9% 55.5% -23.9% -50.6% -100.0% 0.0%
ROIC 0.21
4.36
2.38
-2.29
4.78
8.95
13.90
10.30
5.01
0.18
-3.71
growth rate 1,976.2% -45.4% -100.0% 100.0% 87.2% 55.3% -25.9% -51.4% -96.4% -100.0%
Cur. Ratio 2.15
3.11
2.29
1.92
2.29
2.19
1.71
2.45
3.06
4.34
4.07
growth rate 44.7% -26.4% -16.2% 19.3% -4.4% -21.9% 43.3% 24.9% 41.8% -6.2%
Quick Ratio 1.13
1.54
1.17
1.05
1.24
1.24
0.98
1.07
1.61
3.36
2.90
growth rate 36.3% -24.0% -10.3% 18.1% 0.0% -21.0% 9.2% 50.5% 108.7% -13.7%
Leverage 1.38
1.28
1.37
1.85
1.82
1.73
1.50
1.35
1.28
1.58
1.39
growth rate -7.3% 7.0% 35.0% -1.6% -5.0% -13.3% -10.0% -5.2% 23.4% -12.0%
Balance Sheet Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19 Dec '20
Acct.Receivable 8.90
9.11
12.17
14.77
12.81
16.24
21.78
18.14
20.34
20.12
37.07
growth rate 2.3% 33.7% 21.3% -13.2% 26.8% 34.1% -16.7% 12.2% -1.1% 84.3%
Acct.Payable 7.39
9.43
8.87
4.90
7.62
6.34
9.49
7.47
6.60
15.12
growth rate 27.7% -6.0% -44.8% 55.7% -16.8% 49.6% -21.3% -11.6% 129.1%
Cur.Assets 27.30
28.89
32.96
33.91
32.91
41.26
55.27
62.79
62.41
139.87
171.28
growth rate 5.8% 14.1% 2.9% -3.0% 25.4% 34.0% 13.6% -0.6% 124.1% 22.5%
Total Assets 63.00
61.89
66.83
93.55
96.84
109.72
130.84
135.44
156.45
244.42
399.84
growth rate -1.8% 8.0% 40.0% 3.5% 13.3% 19.3% 3.5% 15.5% 56.2% 63.6%
Cash 5.50
6.33
5.78
6.02
5.86
6.89
10.79
9.66
13.39
89.03
86.33
growth rate 15.1% -8.7% 4.0% -2.7% 17.7% 56.7% -10.5% 38.6% 565.0% -3.0%
Inventory 11.90
12.40
12.48
11.69
12.66
16.10
20.40
32.60
25.10
26.60
40.04
growth rate 4.2% 0.7% -6.4% 8.3% 27.2% 26.7% 59.8% -23.0% 6.0% 50.5%
Cur.Liabilities 12.70
9.29
14.39
17.71
15.05
18.80
32.41
19.38
20.36
32.20
42.12
growth rate -26.9% 54.9% 23.1% -15.0% 24.9% 72.4% -40.2% 5.1% 58.1% 30.8%
Liabilities 17.30
13.46
17.96
29.37
28.03
30.44
43.87
35.00
34.04
89.89
112.79
growth rate -22.2% 33.5% 63.5% -4.6% 8.6% 44.1% -20.2% -2.8% 164.1% 25.5%
LT Debt 0.00
0.00
0.00
0.37
0.23
0.07
6.00
6.00
46.47
49.01
growth rate -38.5% -69.6% 832.5% 0.0% 674.5% 5.5%
Equity 45.80
48.44
48.86
47.12
53.13
63.53
86.98
100.44
122.41
154.36
287.05
growth rate 5.8% 0.9% -3.6% 12.8% 19.6% 36.9% 15.5% 21.9% 26.1% 86.0%
Common Shares 5.00
5.00
5.00
6.00
6.00
7.00
7.00
8.00
8.00
7.00
9.00
growth rate 0.0% 0.0% 20.0% 0.0% 16.7% 0.0% 14.3% 0.0% -12.5% 28.6%
Cash Flow Statement Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19 Dec '20
Capital Expenditures 0.60
1.08
1.51
1.93
2.34
3.77
3.42
3.47
1.36
1.04
0.69
growth rate 80.7% 39.2% 27.9% 21.1% 61.5% -9.4% 1.5% -60.9% -23.1% -34.3%
Cash Dividends 0.00
0.00
1.60
0.00
0.97
0.97
0.97
growth rate -100.0% 0.0% 0.0%
Cash From OA 1.90
4.89
-0.37
5.55
2.13
5.86
10.41
13.29
3.30
-0.66
growth rate 157.3% -100.0% 100.0% -61.7% 175.5% 77.8% 27.7% -75.2% -100.0%
FCF per Share 0.25
1.24
-0.34
-0.80
0.17
-0.19
0.14
0.92
1.03
-0.03
-0.28
growth rate 396.0% -100.0% 0.0% 100.0% -100.0% 100.0% 557.1% 12.0% -100.0% 0.0%
Sale Purchase of Stock 0.12
0.39
0.32
1.43
2.14
2.38
2.45
growth rate 214.5% -17.2% 342.7% 49.9% 11.2% 2.9%
FCF 1.00
4.00
-2.00
-3.00
3.00
-2.00
2.00
7.00
9.00
2.00
-1.00
growth rate 300.0% -100.0% 0.0% 100.0% -100.0% 100.0% 250.0% 28.6% -77.8% -100.0%
Income Statement Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19 Dec '20
Sales 65.50
70.07
72.81
78.34
89.84
104.60
130.08
129.34
127.45
122.66
197.32
growth rate 7.0% 3.9% 7.6% 14.7% 16.4% 24.4% -0.6% -1.5% -3.8% 60.9%
Op.Income 0.40
2.15
1.20
-1.20
2.91
8.56
16.53
18.22
3.79
0.33
1.31
growth rate 436.3% -43.9% -100.0% 100.0% 194.0% 93.2% 10.2% -79.2% -91.4% 300.0%
IBT 0.10
3.37
2.02
-1.39
2.95
8.43
16.50
18.37
3.74
-3.18
-14.51
growth rate 3,266.0% -39.9% -100.0% 100.0% 185.7% 95.9% 11.3% -79.7% -100.0% 0.0%
Net Income 0.00
2.15
1.20
-1.20
2.60
5.24
10.51
9.95
5.85
-1.47
-14.40
growth rate -43.9% -100.0% 100.0% 101.3% 100.6% -5.3% -41.2% -100.0% 0.0%
EPS 0.00
0.40
0.22
-0.21
0.41
0.74
1.43
1.30
0.74
-0.20
-1.66
growth rate -45.0% -100.0% 100.0% 80.5% 93.2% -9.1% -43.1% -100.0% 0.0%
Gross Profit 24.80
29.19
31.10
30.63
35.72
44.21
53.89
58.26
56.64
54.45
81.29
growth rate 17.7% 6.6% -1.5% 16.6% 23.8% 21.9% 8.1% -2.8% -3.9% 49.3%
R&D 1.60
1.65
0.96
1.50
1.41
1.66
2.15
2.00
3.33
8.24
8.77
growth rate 3.1% -41.9% 56.6% -5.7% 17.3% 29.5% -6.7% 66.4% 147.2% 6.5%

Quarterly Statements

Item Name Mar '20 Jun '20 Sep '20 Dec '20 Mar '21
Earnings BIT -0.72
-1.73
0.98
2.80
growth rate 0.0% 100.0% 186.0%
Balance Sheet Mar '20 Jun '20 Sep '20 Dec '20 Mar '21
Acct.Receivable 19.96
32.08
33.09
37.07
growth rate 60.7% 3.2% 12.1%
Acct.Payable 7.14
11.89
12.28
15.12
14.96
growth rate 66.6% 3.3% 23.2% -1.1%
Cur.Assets 245.66
158.38
166.23
171.28
322.76
growth rate -35.5% 5.0% 3.0% 88.5%
Total Assets 350.98
376.90
383.88
399.84
569.57
growth rate 7.4% 1.9% 4.2% 42.5%
Cash 191.25
79.19
84.51
86.33
238.46
growth rate -58.6% 6.7% 2.2% 176.2%
Inventory 29.06
40.77
39.35
40.04
39.36
growth rate 40.3% -3.5% 1.8% -1.7%
Cur.Liabilities 21.91
32.85
33.52
42.12
37.79
growth rate 50.0% 2.0% 25.7% -10.3%
Liabilities 80.32
106.94
109.16
112.79
144.30
growth rate 33.1% 2.1% 3.3% 27.9%
LT Debt 47.98
50.04
51.73
49.01
growth rate 4.3% 3.4% -5.3%
Equity 270.64
270.05
274.88
287.05
growth rate -0.2% 1.8% 4.4%
Common Shares 0.08
0.09
0.10
0.10
growth rate 20.5% 1.1% 0.0%
Cash Flow Statement Mar '20 Jun '20 Sep '20 Dec '20 Mar '21
Capital Expenditures 0.21
0.11
0.17
0.20
growth rate -49.5% 60.4% 17.7%
Cash Dividends
growth rate
Cash From OA -4.76
-8.33
4.99
7.45
1.34
growth rate 0.0% 100.0% 49.1% -82.0%
Sale Purchase of Stock
growth rate
FCF -4.97
-8.44
4.82
7.25
growth rate 0.0% 100.0% 50.2%
Income Statement Mar '20 Jun '20 Sep '20 Dec '20 Mar '21
Sales 30.65
45.71
56.64
64.32
growth rate 49.1% 23.9% 13.6%
Op.Income -0.72
-1.73
0.98
2.80
growth rate 0.0% 100.0% 186.0%
IBT -6.95
-6.69
-1.89
1.01
growth rate 0.0% 0.0% 100.0%
Net Income -5.29
-6.36
-5.22
2.47
1.87
growth rate 0.0% 0.0% 100.0% -24.1%
EPS
growth rate
Gross Profit 13.45
17.87
23.40
26.57
25.47
growth rate 32.9% 31.0% 13.5% -4.2%
R&D 2.13
1.70
2.20
2.75
1.19
growth rate -20.3% 29.5% 25.2% -56.9%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

F (8.11)

YOY Growth Grade:

E (27.78)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 106.67 197.74 51.38
EPS / Growth 69.7% 0.97 18.5%

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 38.0%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 18.5% 42.1% 42.1%
Future PE 37.00 80.73 80.73
Future EPS 5.31 32.59 32.59
Value Price
MOS %
48.59
-74.7%
650.42
238.1%
650.42
238.1%
MOS Price 24.29 325.21 325.21
IRT 20.37 11.60 11.60

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.